1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment | Patent Number 08722684

US 08722684 B2
Application Number12301061
Publication NumberUS 20100297240 A1
Pendency6 years, 11 months, 4 days
Filled DateJun 15, 2007
Priority DateJun 16, 2006
Publication DateNov 25, 2010
Expiration DateJun 15, 2026
Inventor/ApplicantsAndre Faldt
Heidi Lopez de Diego
Arne Mork
Nicholas Moore
Michael Harold Rock
Morten Jorgensen
Michael J. Mealy
Jorgen Brodersen
Rene Holm
Benny Bang-Andersen
Tine Bryan Stensbol
Lone Munch Ringgaard
Heidi Lopez De Diego
ExaminesPOLANSKY, GREGG
Art Unit1621
Technology Center1600
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.